Method of treating androgen-dependent disorders
US6710037B2 · kind B2 · utility
17Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 1, 2002 |
| Grant date | Mar 23, 2004 |
| Priority date | — |
| Expiry date | May 1, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/10343
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel methods of treating subjects afflicted with an androgen-dependent disorder, such as prostate cancer and benign prostatic hyperplasia are disclosed. Specifically, methods of treating androgen-dependent disorders by introducing a polypeptide or a polynucleotide encoding the polypeptide, which enhances inactivation of active androgens, are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.